After US, Bharat Biotech to Manufacture Covaxin in Canada

Hyderabad: India’s first indigenous COVID-19 vaccine ‘Covaxin’ will now be sold and manufactured in Canada as Bharat Biotech has extended its tie-up with biopharmaceutical company Ocugen Inc to expand to the Canadian market after the US. Bharat Biotech will have exclusive co-development, manufacturing, and commercialisation rights of Covaxin in Canada, in addition to its existing rights in the United States.

.

Read more at: https://www.india.com/news/india/after-us-bharat-biotech-ties-up-with-ocugen-for-sale-manufacture-of-covaxin-in-canada-4714336/

.

Visit www.werindia.com OR Hindi.werindia.com to read news from 500+ news sources... आपका अपना डिजिटल अख़बार |

 
• 10 Jun 2021
• WerIndia